World Conference on Cancer Research and Novel Drug Development WCCRDD on September 14-16, 2026 in Tokyo, Japan

Cancer Biology & Molecular Oncology

Genomics, epigenetics, tumor microenvironment, cancer metabolism.

Translational Cancer Research

Bench-to-bedside approaches, biomarkers, companion diagnostics.

Novel Drug Discovery & Development

Small molecules, biologics, ADCs, PROTACs, RNA-based therapeutics.

Immuno-Oncology & Cell Therapies

Checkpoint inhibitors, CAR-T/TCR therapies, cancer vaccines.

Precision & Personalized Oncology

Targeted therapies, pharmacogenomics, real-world evidence.

Clinical Trials & Regulatory Science

Trial design, Phase I–IV studies, regulatory pathways, ethics.

AI, Bioinformatics & Digital Oncology

AI/ML in drug discovery, imaging, data integration, digital biomarkers.

Radiation Oncology & Surgical Advances

Novel radiotherapy techniques, image-guided surgery, robotics.

Resistance Mechanisms & Combination Therapies

Drug resistance, synergistic regimens, treatment sequencing.

Cancer Prevention, Early Detection & Screening

Liquid biopsy, imaging innovations, risk stratification.

Pediatric & Rare Cancers

Orphan indications, tailored clinical strategies.

Oncology Nursing, Patient Care & Survivorship

Supportive care, quality of life, survivorship programs.

Industry–Academia Collaboration & Technology Transfer

Partnerships, licensing, startups, venture funding.

Health Economics, Policy & Market Access

Pricing, reimbursement, global access, outcomes research.

Name: Elena
Website: https://www.cancer.thesciencequest.org/
Address: Tokyo Prince Hotel, Tokyo, Japan

The World Conference on Cancer Research and Novel Drug Development (WCCRDD-2026), scheduled for September 14-16, 2026, in Tokyo, Japan. will serve as a premier platform for oncologists, researchers, pharmaceutical experts, and healthcare professionals to explore the latest advancements in cancer treatment and drug discovery.